Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.16 USD | -9.41% | -8.61% | +9.03% |
05-09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
05-08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.03% | 424M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CCCC Stock
- News C4 Therapeutics, Inc.
- UBS Adjusts C4 Therapeutics Price Target to $26 From $64, Maintains Buy Rating